Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Topical nitroglycerin spray effectively prevents scalp necrosis in hair transplant patients.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Using high doses and multiple drugs with steroids is risky and should be prevented.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Plant extracts may help prevent or reverse hair graying.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Natural skincare products may help reduce sun damage and support the skin's daily cycle.

Long-term opioid use can cause a serious condition where the adrenal glands don't work properly, which doctors should watch out for.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Finasteride may help reduce opioid use.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.